The Consumer Products Safety Unit (F.2), part of Health, Consumers and Reference Materials Directorate-F at the JRC in Ispra (Italy), is looking for a trainee for the Nanobiotechnology laboratory.
Nanotechnology based health products offer promising opportunities to address unmet medical needs. However, the special characteristics of nanomaterials used in medical products require a timely preparation of the regulatory frameworks in order to allow a smooth translation of these innovative products to the market.
The Horizon 2020 project REFINE (http://refine-nanomed.com/) that is aiming to develop a Regulatory Science Framework for the risk-benefit assessment of medical products based on nanotechnology is currently anticipating and addressing regulatory needs for the next generation nanomedicines. In particular, the interaction of the material with biological systems requires a close monitoring of the scientific literature in order to recognize upcoming challenges with innovative materials. The huge increase of scientific literature in this field as well as the variety and complexity of possible biological effects require the use of automatic text mining tools for an objective and effective monitoring of the field. A proper preparation of data, their import in a framework (e.g. Excel) for further filtering and management will allow the analysis of early signals of adverse effects requiring regulatory awareness.
He/She will get an overview on the regulatory frameworks relevant for nanomedicines and contribute to the REFINE project. In addition, the trainee will have the opportunity to gain insights into automatic text and tech mining tools, as well as the analysis of results.
For general eligibility requirements, please read the rules governing the traineeship scheme of the JRC:
European Nanomedicine Characterisation Laboratory (EUNCL)